BETTELLI, Stefania Raffaella
 Distribuzione geografica
Continente #
NA - Nord America 5.257
EU - Europa 2.499
AS - Asia 641
AF - Africa 10
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 8.426
Nazione #
US - Stati Uniti d'America 5.226
GB - Regno Unito 827
IT - Italia 417
SE - Svezia 313
IE - Irlanda 280
DE - Germania 265
CN - Cina 212
HK - Hong Kong 142
UA - Ucraina 139
TR - Turchia 105
FI - Finlandia 79
BG - Bulgaria 56
JP - Giappone 50
FR - Francia 41
IN - India 38
CA - Canada 31
VN - Vietnam 25
BE - Belgio 20
PK - Pakistan 17
MY - Malesia 13
PL - Polonia 10
IR - Iran 9
RU - Federazione Russa 9
CH - Svizzera 6
DK - Danimarca 6
RO - Romania 6
TW - Taiwan 6
EU - Europa 5
GR - Grecia 5
KR - Corea 5
SG - Singapore 5
BR - Brasile 4
NO - Norvegia 4
TZ - Tanzania 4
AU - Australia 3
IQ - Iraq 3
AT - Austria 2
BO - Bolivia 2
CL - Cile 2
EG - Egitto 2
IL - Israele 2
MK - Macedonia 2
PH - Filippine 2
PT - Portogallo 2
SI - Slovenia 2
TH - Thailandia 2
UG - Uganda 2
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
AR - Argentina 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
ES - Italia 1
HU - Ungheria 1
ID - Indonesia 1
KE - Kenya 1
LB - Libano 1
MA - Marocco 1
ME - Montenegro 1
MT - Malta 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 8.426
Città #
Fairfield 817
Southend 660
Chandler 497
Woodbridge 437
Ashburn 381
Houston 345
Seattle 341
Ann Arbor 294
Cambridge 284
Dublin 279
Jacksonville 261
Dearborn 260
Wilmington 254
Nyköping 226
Hong Kong 137
Modena 95
Beijing 90
New York 86
Izmir 68
Princeton 60
San Diego 58
Sofia 56
Eugene 50
Helsinki 48
Tokyo 45
Fremont 32
Falls Church 31
Bologna 30
Shanghai 26
London 25
Milan 25
Bremen 24
Dong Ket 23
Ottawa 19
Brussels 17
Redwood City 17
Norwalk 16
Lahore 15
Rome 14
Lansdale 11
Los Angeles 11
Grafing 9
Kunming 9
Nanjing 9
San Giuliano Milanese 9
Boardman 8
Calcinaia 7
Castelnuovo Berardenga 7
Charleston 7
Des Moines 7
Kielce 7
Parma 7
Berlin 6
Hefei 6
Padova 6
San Mateo 6
Tulare 6
Venezia 6
Bangalore 5
Kilburn 5
Leicester 5
Mumbai 5
Nanchang 5
Phoenix 5
Sassuolo 5
Shenyang 5
Taipei 5
Vernon 5
Ardabil 4
Athens 4
Chicago 4
Frankfurt am Main 4
Islington 4
Lavello 4
Lüleburgaz 4
Novate Milanese 4
Rimini 4
San Francisco 4
San Marco 4
Suwon 4
Verona 4
Acton 3
Augusta 3
Bronx 3
Castelvetrano 3
Chengdu 3
Chongqing 3
Edinburgh 3
Guangzhou 3
Jodhpur 3
Kernersville 3
Medolla 3
Monmouth Junction 3
Monza 3
Napoli 3
Oslo 3
Pavia 3
Pisa 3
Toronto 3
Turin 3
Totale 6.746
Nome #
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 272
Assessment of freezing effects and diagnostic potential of BioBank healthy and neoplastic breast tissues through HR-MAS NMR spectroscopy 248
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 212
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 211
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis 209
Poorly differentiated clusters (PDC) in colorectal cancer: What is and ought to be known. 198
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer 195
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 195
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 192
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.. 188
Prediction of distant recurrence in resected stage I and II lung adenocarcinoma 186
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. 186
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer 184
Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients 180
Cytomegalovirus infection of the upper gastrointestinal tract: a clinical and pathological study of 30 cases. 179
Atypical Spitzoid melanocytic tumors:A morphological, mutational, and FISH analysis 175
Clinical and molecular analysis of long-term HER2 positive metastatic breast cancer survivors. 175
Alveolar rhabdomyosarcoma of the uterine cervix. A case report confirmed by FKHR break-apart rearrangement using a fluorescence in situ hybridization probe on paraffin-embedded tissues. 172
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 170
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 169
Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy. 167
Molecular Profile, as detected with Mass-Array Spectrometry (Sequenom platform), in primary and metastatic breast carcinoma treated with Exemestane + Everolimus 166
Durable remission in a patient with leptomeningeal relapse of a MYC/BCL6-positive double-hit DLBCL treated with lenalidomide monotherapy 164
ASSESSMENT OF FREEZING EFFECTS AND DIAGNOSTIC POTENTIAL OF BIOBANK HEALTHY AND NEOPLASTIC BREAST TISSUES THROUGH HR-MAS NMR SPECTROSCOPY 164
Alterations of 9p21 analysed by FISH and MLPA distinguish atypical spitzoid melanocytic tumours from conventional Spitz's nevi but do not predict their biological behaviour. 163
Cerebrospinal fluid cytology in a case of primary diffuse leptomeningeal and pineal melanocytic lesion, with histological confirmation 159
Does HPV play a role in the etiopathogenesis of ameloblastoma? An immunohistochemical, in situ hybridization and polymerase chain reaction study of 18 cases using laser capture microdissection 158
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status 154
Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer 154
Preoperative letrozole plus lapatinib/placebo for HR+/HER2 negative operable breast cancer: biomarker analyses of the randomized phase II LET-LOB study 150
EGFR polysomy in squamous cell carcinoma of the thyroid. Report of two cases and review of the literature 148
Expression of estrogen receptor in hemangioma of the uterine cervix: Reports of three cases and review of the literature 147
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus. 144
Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER+) primary breast cancer and paired recurrence 142
The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung. 141
Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung 139
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status. 135
Clinical impact and prognostic role of KRAS/BRAF/PIK3CA mutations in stage I colorectal cancer 129
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 125
Prediction of Distant Recurrence-Free Survival in Resectable Lung Adenocarcinoma. 125
Trans-CHER-Lob: A Biomarker Analysis of the Randomized Phase II Study of Neoadjuvant Chemotherapy Plus Trastuzumab, Lapatinib or Combined Trastuzumab and Lapatinib in HER2 Positive Operable Breast Cancer. 124
Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts 124
High-Resolution Melting is a sensitive, cost-effective, time-saving technique for BRAF V600E detection in thyroid FNAB washing fluid: a prospective cohort study 123
FISH analysis in cell touch preparations and cytological specimens from formalin-fixed fetal autopsies. 118
Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridization 115
KRAS, NRAS, BRAF mutations and high counts of poorly differentiated clusters of neoplastic cells in colorectal cancer: Observational analysis of 175 cases 115
Evaluation of the effects of cryopreservation on Modena Biobank tissue samples through HR-MAS NMR 106
Prognostic role of HER2 loss after neoadjuvant therapy in patients with HER2-positive operable breast cancer 104
Correlation between CD133 expression and mgmt status in recurrences melanoma 100
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS 93
35. PREDICTORS OF HER2 FISH POSITIVITY IN PRIMARY BREAST CANCER DIAGNOSIS SCORED 2+ WITH IHC: RESULTS OF A SINGLE INSTITUTION ANALYSIS 92
Morphological analysis of three extrathoracic bronchogenic cysts simulating neoplasms 86
Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting 84
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 76
Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters 71
Deepening the knowledge of ros1 rearrangements in non-small cell lung cancer: Diagnosis, treatment, resistance and concomitant alterations 62
Unexpected tumor response to palliative pelvic radiotherapy in mismatch repair-deficient advanced prostate cancer: a case report 45
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 42
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice 2
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 1
Totale 8.553
Categoria #
all - tutte 31.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019616 0 0 0 0 0 0 0 0 0 87 233 296
2019/20201.867 133 81 64 148 191 265 332 206 230 56 105 56
2020/20211.642 147 88 135 183 223 89 103 182 103 173 114 102
2021/20221.179 52 128 94 71 40 91 54 58 121 123 202 145
2022/20231.520 149 164 117 122 121 178 35 115 400 13 46 60
2023/2024787 18 53 47 91 160 68 194 114 23 19 0 0
Totale 8.553